We are live on ! Find out more
IMA

ImageneBio Inc
IMA

39 hedge funds and large institutions have $86.2M invested in ImageneBio Inc in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

24% more capital invested

Capital invested by funds: $69.8M → $86.2M (+$16.4M)

15% more funds holding

Funds holding: 34 → 39 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.29% less ownership

Funds ownership: 6.04% → 5.74% (-0.29%)

Holders
39
Holders Change
+5
Holders Change %
+14.71%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
15
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$2.55M
2
O
OrbiMed
New York
+$966K
3
Millennium Management
Millennium Management
New York
+$378K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$152K
5
Jane Street
Jane Street
New York
+$147K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$7.56M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.57M
3
OMC
Oasis Management Company
Cayman Islands
-$372K
4
E
Ergoteles
New York
-$46.8K
5
TRCT
Tower Research Capital (TRC)
New York
-$39.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$62.6K +$69.5K +1,512 New
Morgan Stanley
27
Morgan Stanley
New York
$46.5K +$37.6K +818 +267%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$45K – – –
Charles Schwab
29
Charles Schwab
California
$41.6K – – –
Bank of America
30
Bank of America
North Carolina
$23.7K -$8.5K -185 -24%
Citigroup
31
Citigroup
New York
$14.8K +$13.8K +301 +519%
TRCT
32
Tower Research Capital (TRC)
New York
$13K -$39.7K -863 -74%
BWM
33
Baystate Wealth Management
Massachusetts
$10.3K – – –
JP Morgan Chase
34
JP Morgan Chase
New York
$3K – – –
UBS Group
35
UBS Group
Switzerland
$2.15K +$2.39K +52 New
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$1K +$1.01K +22 New
Wells Fargo
37
Wells Fargo
California
$942 – – –
US Bancorp
38
US Bancorp
Minnesota
$752 +$827 +18 New
FFA
39
Farther Finance Advisors
California
$173 – – –
OMC
40
Oasis Management Company
Cayman Islands
– -$372K -11,667 Closed
E
41
Ergoteles
New York
– -$46.8K -1,467 Closed
1
2

IMA Hedge Fund Activity: Q1 2023 in Review

39 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2023, worth a combined $86.2M — up 24% from $69.8M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new IMA positions and 2 closed out — a net gain of 5 holders — while 15 added to existing stakes and 6 trimmed.

The largest buyer was BVF Inc, adding an estimated $2.55M. The largest seller was Citadel Advisors, cutting an estimated $7.56M.

  • 39 institutional investors held ImageneBio Inc (IMA) as of Q1 2023, up from 34 in Q4 2022.
  • Funds reported $86.2M of ImageneBio Inc stock for Q1 2023, up 24% quarter-over-quarter.
  • 7 funds opened new ImageneBio Inc positions in Q1 2023 and 2 closed out, a net change of +5 holders.
  • The largest ImageneBio Inc buyer in Q1 2023 was BVF Inc, an estimated $2.55M added.
  • The largest ImageneBio Inc seller in Q1 2023 was Citadel Advisors, an estimated $7.56M sold.

Based on aggregated 13F filings for Q1 2023.